Open AccessCON (“The window is closed”): In patients with cirrhosis with ascites, the clinical risks of nonselective beta‐blocker outweigh the benefits and should NOT be prescribed
Author(s) -
Aday Ariel W.,
Rich Nicole E.,
Mufti Arjmand R.,
Tujios Shannan R.
Publication year - 2018
Publication title -
clinical liver disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 14
ISSN - 2046-2484
DOI - 10.1002/cld.699
Subject(s) - cirrhosis , ascites , therapeutic window , medicine , beta blocker , window (computing) , beta (programming language) , gastroenterology , pharmacology , computer science , heart failure , operating system , programming language
Watch a video presentation of this article
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom